Clinical trial
Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in…
NCT00280540 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00280540 |
|---|---|
| Title | Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension |
| Official title | A 6-week Treatment Regimen Study to Evaluate the Efficacy of Initial High Dose Valsartan Monotherapy (160 mg) or Combo Therapy (Valsartan + Hydrochlorothiazide, 160/12.5 mg) to Conventional Low-dose Valsartan Monotherapy (80 mg) in Managing Patients With Hypertension |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Valsartan/Hydrochlorothiazide |
| Enrollment | 648 |
| Start date | Dec 1, 2005 |
| Primary completion | Aug 1, 2006 |
| First posted | Jan 23, 2006 |
| Last update posted | Nov 9, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: